1. Home
  2. PSNL vs MCS Comparison

PSNL vs MCS Comparison

Compare PSNL & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • MCS
  • Stock Information
  • Founded
  • PSNL 2011
  • MCS 1935
  • Country
  • PSNL United States
  • MCS United States
  • Employees
  • PSNL N/A
  • MCS N/A
  • Industry
  • PSNL Medical Specialities
  • MCS Movies/Entertainment
  • Sector
  • PSNL Health Care
  • MCS Consumer Discretionary
  • Exchange
  • PSNL Nasdaq
  • MCS Nasdaq
  • Market Cap
  • PSNL 518.8M
  • MCS 478.7M
  • IPO Year
  • PSNL 2019
  • MCS N/A
  • Fundamental
  • Price
  • PSNL $5.82
  • MCS $16.09
  • Analyst Decision
  • PSNL Strong Buy
  • MCS Strong Buy
  • Analyst Count
  • PSNL 4
  • MCS 4
  • Target Price
  • PSNL $8.13
  • MCS $24.75
  • AVG Volume (30 Days)
  • PSNL 824.9K
  • MCS 210.0K
  • Earning Date
  • PSNL 11-05-2025
  • MCS 10-30-2025
  • Dividend Yield
  • PSNL N/A
  • MCS 1.74%
  • EPS Growth
  • PSNL N/A
  • MCS N/A
  • EPS
  • PSNL N/A
  • MCS 0.47
  • Revenue
  • PSNL $80,317,000.00
  • MCS $734,999,000.00
  • Revenue This Year
  • PSNL N/A
  • MCS $13.06
  • Revenue Next Year
  • PSNL $29.83
  • MCS $4.18
  • P/E Ratio
  • PSNL N/A
  • MCS $34.34
  • Revenue Growth
  • PSNL 0.36
  • MCS 13.65
  • 52 Week Low
  • PSNL $2.83
  • MCS $14.13
  • 52 Week High
  • PSNL $7.79
  • MCS $23.16
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 60.46
  • MCS 55.88
  • Support Level
  • PSNL $5.48
  • MCS $15.30
  • Resistance Level
  • PSNL $6.26
  • MCS $16.68
  • Average True Range (ATR)
  • PSNL 0.33
  • MCS 0.42
  • MACD
  • PSNL 0.11
  • MCS 0.10
  • Stochastic Oscillator
  • PSNL 72.86
  • MCS 65.09

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About MCS Marcus Corporation (The)

Marcus Corp is engaged in two business segments, which are movie theatres and Hotels and Resorts. The movie theatres segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio and others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.

Share on Social Networks: